Results 21 to 30 of about 8,351 (164)

Onset and duration of action of lokivetmab in a canine model of IL‐31 induced pruritus

Veterinary Dermatology, Volume 32, Issue 6, Page 681-e182, December 2021., 2021
Onset of antipruritic action of lokivetmab in dogs. Laboratory‐bred beagle dogs were dosed subcutaneously with either placebo or lokivetmab at 2.0 mg/kg on Day (D) 0. Approximately 2.5 h post‐dosing, pruritus was induced using canine interleukin (IL)‐31. Animals were observed for pruritic behaviours for a total of 2 h (3–5 h post‐treatment with placebo
Timothy J. Fleck, Lori R. Norris, Sean Mahabir, Rodney R. Walters, Olivier Martinon, Steven A. Dunham, Andrea J. Gonzales   +6 more
wiley   +1 more source

A masked, randomised clinical trial evaluating the efficacy and safety of lokivetmab compared to saline control in client‐owned dogs with allergic dermatitis

Veterinary Dermatology, Volume 32, Issue 5, Page 477-e131, October 2021., 2021
Background – Interleukin (IL)‐31 is an important mediator in canine atopic dermatitis (cAD) and also may be dysregulated in other allergic diseases. Hypothesis/Objectives – To demonstrate the efficacy and safety of lokivetmab (canine anti‐IL‐31 monoclonal antibody) for treatment of pruritus associated with allergic dermatitis in dogs.
Leen Van Brussel, Hilde Moyaert, Monica Escalada, Sean P. Mahabir, Michael R. Stegemann   +4 more
wiley   +1 more source

Treatment of equine sarcoids using recombinant poxviruses expressing feline interleukin‐2

Veterinary Dermatology, Volume 32, Issue 3, Page 283-e77, June 2021., 2021
Background – Interleukin (IL)‐2 stimulates antitumour immunity and is successfully used for the treatment of different neoplasias. Hypothesis/Objectives –Canarypox virus locally expressing feline IL‐2 is safe and can be used to treat equine sarcoids. Conclusions –Treatment of equine sarcoids with recombinant canarypox virus expressing feline IL‐2 seems
Johanna Loschelder‐Ostrowski, Judith Christine Winter, Roswitha Merle, Robert Klopfleisch, Heidrun Gehlen   +4 more
wiley   +1 more source

Serum concentrations of IL‐31 in dogs with nonpruritic mast cell tumours or lymphoma

Veterinary Dermatology, Volume 31, Issue 6, Page 466-e124, December 2020., 2020
Background The aim of this study was to compare serum interleukin (IL)‐31 concentrations in dogs with lymphoma and mast cell tumours (MCT) without pruritus to those of healthy dogs. Hypothesis/Objectives To determine if IL‐31 plays a role in tumour pathogenesis and if IL‐31 could be a biological marker for disease progression.
Nataliia Ignatenko, Andrea J. Gonzales, James E. Messamore, Johannes Hirschberger, Laura Udraite‐Vovk, Teresa M.S.A. Boehm, Karin Troedson, Csilla Fejos, Ralf S. Mueller   +8 more
wiley   +1 more source

Toll‐like receptor‐ligand induced thymic stromal lymphopoietin expression in primary equine keratinocytes

Veterinary Dermatology, Volume 31, Issue 2, Page 154-e30, April 2020., 2020
Background Thymic stromal lymphopoietin (TSLP) plays a key role in the development of allergic inflammation. Little is known about possible triggers of equine TSLP expression. Hypothesis To investigate TSLP expression in equine insect bite hypersensitivity (IBH) skin lesions.
Iva Cvitas, Arnaud Galichet, Shui Chu Ling, Eliane J. Müller, Eliane Marti   +4 more
wiley   +1 more source

Long‐term use of lokivetmab in dogs with atopic dermatitis

Veterinary Dermatology, Volume 35, Issue 6, Page 683-693, December 2024.
Background – Lokivetmab, a caninised monoclonal antibody against interleukin (IL)‐31, is an effective treatment for the pruritus associated with canine atopic dermatitis (cAD). Objectives – To investigate the efficacy and safety of lokivetmab during long‐term treatment defined as at least three consecutive lokivetmab injections in atopic dogs under ...
Bettina Kasper, Yury Zablotski, Ralf S. Mueller   +2 more
wiley   +1 more source

Analysis of the immunomodulatory properties of mycobacterium cell wall fraction on the cytokine production of peripheral blood mononuclear cells of healthy dogs

Veterinary Dermatology, Volume 35, Issue 6, Page 595-604, December 2024.
Background – Mycobacterium cell wall fraction (MCWF) is derived from nonpathogenic Mycobacterium phlei and is used as an immunomodulatory compound in clinical practice, yet its mode‐of‐action requires further research. Objective – To evaluate the host response to MCWF in canine peripheral blood mononuclear cells (PBMCs) by using enzyme‐linked ...
Robert Ward, Geoffrey A. Wood, Charlotte Pye, Khalil Karimi, Anthony Yu, Myles St‐Denis, Katherine Blake, Sugandha Raj, Samson Oladokun, Shayan Sharif   +9 more
wiley   +1 more source

Update on the role of cytokines and chemokines in canine atopic dermatitis

Veterinary Dermatology, Volume 35, Issue 1, Page 25-39, February 2024.
Background – Cytokines and chemokines play central roles in the pathogenesis of canine atopic dermatitis (cAD). Numerous studies have been published and provide new insights into their roles in cAD. Objectives – To summarise the research updates on the role of cytokines and chemokines in the pathogenesis of cAD since the last review by the ...
Chie Tamamoto‐Mochizuki, Domenico Santoro, Manolis N. Saridomikelakis, Melissa N. C. Eisenschenk, Patrick Hensel, Cherie Pucheu‐Haston, for the International Committee on Allergic Diseases of Animals (ICADA)   +6 more
wiley   +1 more source

International clinical practice recommendations on the definition, diagnosis, assessment, intervention, and psychosocial aspects of developmental coordination disorder – Chinese (Mandarin) translation

Developmental Medicine &Child Neurology, Volume 61, Issue 3, Page E1-E35, March 2019., 2019
目的 本国际临床指南由欧洲残疾儿童学会（the European Academy of Childhood Disability，EACD）牵头制定，旨在解决发育性协调障碍（developmental coordination disorder，DCD）的定义、诊断、评估、干预以及与社会心理方面的临床应用关键问题。 方法 本指南针对五个领域的关键问题，通过文献综述和专家团队的正式讨论达成共识。为保证指南的循证基础，以“机制”、“评估”和“干预”为检索词, 对2012年更新以来提出的最新建议以及新增的“社会心理问题”和“青少年/成人”为检索词进行检索。根据牛津大学循证医学中心证据等级 (证据水平 [level of evidence, LOE]1–4) 将结果进行分类，最终转化为指南建议。并由国际 ...
Jing Hua, Wenchong Du, Xiaotian Dai, Meiqin Wu, Xianying Cai, Min Shen, Liping Zhu   +6 more
wiley   +1 more source

Effects of mizoribine tablets on expression of Toll-like receptor 4 in peripheral blood mononuclear cells in children with Henoch-Sch■nlein purpura nephritis

Linchuang shenzangbing zazhi, 2020
目的探讨咪唑立宾片对紫癜性肾炎患儿外周血单个核细胞Toll样受体4(Toll-like receptor 4,TLR4)表达的影响。方法选取2015年1月至2018年12月华中科技大学同济医学院附属武汉儿童医院肾脏专科住院及门诊随访资料完整的紫癜性肾炎(Ⅱb级)患儿,共47例。分为糖皮质激素组和咪唑立宾组。检测两组治疗前后24 h尿蛋白定量、血清白细胞介素6、肿瘤坏死因子α及外周血单个核细胞TLR4 mRNA表达情况。结果与治疗前比较,两组在治疗6个月、12个月时24 h尿蛋白定量均显著下降 ...
丁娟娟, 宋娜, 栾江威
doaj